Multisystem Inflammatory Syndrome in Children (MIS-C): A Review of Short- and Long-Term Complications
نویسندگان
1 Hematology and Oncology Research Center, Non-communicable Diseases Research Institute, Shahid Sadoughi University of Medical Sciences, Yazd, Iran - Hematology and Oncology Research Center, Non-communicable Diseases Research Institute, Shahid Sadoughi University of Medical Sciences, Yazd, Iran
2 Children Growth Disorder Research Center, Shahid Sadoughi University of Medical Sciences, Yazd, Iran - Children Growth Disorder Research Center, Shahid Sadoughi University of Medical Sciences, Yazd, Iran
3 Children Growth Disorder Research Center, Shahid Sadoughi University of Medical Sciences, Yazd, Iran - Children Growth Disorder Research Center, Shahid Sadoughi University of Medical Sciences, Yazd, Iran
4 Children Growth Disorder Research Center, Shahid Sadoughi University of Medical Sciences, Yazd, Iran - Children Growth Disorder Research Center, Shahid Sadoughi University of Medical Sciences, Yazd, Iran
5 Children Growth Disorder Research Center, Shahid Sadoughi University of Medical Sciences, Yazd, Iran - Children Growth Disorder Research Center, Shahid Sadoughi University of Medical Sciences, Yazd, Iran
doi
10.18502/ijpho.v16i1.20428چکیده
Multisystem Inflammatory Syndrome in Children (MIS-C) is a rare but serious post-infection disorder associated with SARS-CoV-2 infection, typically occurring 2-6 weeks after acute COVID-19. The syndrome is characterized by persistent fever, multisystem organ impairment, and laboratory evidence of inflammation. The affected individuals require prompt diagnosis and treatment to avoid morbidity. The ...
